| 0 (0%) | 12-27 00:23 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 15.26 |
1-year : | 16.76 |
| Resists | First : | 13.06 |
Second : | 14.35 |
| Pivot price | 13.08 |
|||
| Supports | First : | 10.98 |
Second : | 9.14 |
| MAs | MA(5) : | 12.61 |
MA(20) : | 13.13 |
| MA(100) : | 13.74 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 9.1  |
D(3) : | 7.6 |
| RSI | RSI(14): 44.5 |
|||
| 52-week | High : | 27.12 | Low : | 10.86 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IART ] has closed above bottom band by 22.6%. Bollinger Bands are 42.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 12.84 - 12.92 | 12.92 - 12.98 |
| Low: | 12.37 - 12.45 | 12.45 - 12.52 |
| Close: | 12.5 - 12.63 | 12.63 - 12.75 |
Fri, 26 Dec 2025
How strong is IART stock revenue growth - Cup and Handle Formations & Outstanding Capital Returns - bollywoodhelpline.com
Thu, 25 Dec 2025
At US$12.66, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely? - Yahoo Finance
Tue, 23 Dec 2025
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Maintains Target Price $13 - 富途牛牛
Mon, 22 Dec 2025
Integra LifeSciences Holdings Corporation $IART Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Thu, 18 Dec 2025
Integra LifeSciences: Potential Only Takes You So Far Without Execution (NASDAQ:IART) - Seeking Alpha
Wed, 17 Dec 2025
Trading Systems Reacting to (IART) Volatility - Stock Traders Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 78 (M) |
| Shares Float | 59 (M) |
| Held by Insiders | 13.9 (%) |
| Held by Institutions | 95.5 (%) |
| Shares Short | 6,650 (K) |
| Shares Short P.Month | 6,900 (K) |
| EPS | -6.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.32 |
| Profit Margin | -30.2 % |
| Operating Margin | 9.9 % |
| Return on Assets (ttm) | 2.5 % |
| Return on Equity (ttm) | -38.8 % |
| Qtrly Rev. Growth | 5.5 % |
| Gross Profit (p.s.) | 12.12 |
| Sales Per Share | 21.05 |
| EBITDA (p.s.) | 4.09 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 89 (M) |
| Levered Free Cash Flow | 90 (M) |
| PE Ratio | -1.96 |
| PEG Ratio | 0 |
| Price to Book value | 0.94 |
| Price to Sales | 0.59 |
| Price to Cash Flow | 11 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|